Literature DB >> 23322886

Prognostic value of walk distance, work, oxygen saturation, and dyspnea during 6-minute walk test in COPD patients.

Rafael Golpe1, Luis A Pérez-de-Llano, Lidia Méndez-Marote, Alejandro Veres-Racamonde.   

Abstract

BACKGROUND: Distance walked during the 6-min walk test (6MWT) predicts mortality in COPD. The body weight of the patient affects the work required to walk. Calculated work during the 6MWT (6MWT work) may account for differences in walk distance resulting from change in body weight. Thus, 6MWT work might be a better predictor of mortality than distance walked. This study was designed to test this hypothesis and to assess if other variables measured during the 6MWT, like continuous oximetry recording, offered additional prognostic information.
METHODS: This was a retrospective analysis of prospectively collected data; 104 COPD patients were studied. 6MWT was performed in all cases. 6MWT work was calculated as body weight (in kg) × distance walked (in m). Receiver operating characteristic curves were used to assess the value of variables to predict mortality. Additional analysis was performed using Kaplan-Meier survival plots and Cox proportional hazards regression models.
RESULTS: Mean follow-up was 590 ± 472 d. Eleven subjects (10.6%) died. 6MWT work was not better than distance walked to predict mortality (area under the curve 0.77 for 6MWT work vs 0.80 for distance; difference 0.03, 95% CI -0.05 to 0.12, P = .45). Subjects who died had more dyspnea (measured using the Borg scale) after the 6MWT (8.5 vs 4.0, P < .001), lower baseline SpO2 (85% vs 93%, P = .001), worse oxygen saturation during the 6MWT (mean SpO2 while walking 74.0% vs 86.6%, P = .02) and walked less distance (255 m vs 480 m, P = .001). On multivariate analysis, only 6MWT distance and dyspnea after the test correlated independently with mortality (P = .005 for both variables).
CONCLUSIONS: 6MWT work was not more useful than 6MWT distance to predict mortality. The study confirms that 6MWT distance and dyspnea on exertion are key elements in prognostic evaluation in COPD, while the value of exercise oxygen desaturation is less clear.

Entities:  

Keywords:  6-min walk test; chronic obstructive; mortality; oximetry; prognosis; pulmonary diseases; work capacity evaluation

Mesh:

Substances:

Year:  2013        PMID: 23322886     DOI: 10.4187/respcare.02290

Source DB:  PubMed          Journal:  Respir Care        ISSN: 0020-1324            Impact factor:   2.258


  15 in total

1.  Modified six-minute walk test: number of steps per second.

Authors:  Naoto Burioka; Akari Imada; Akiko Kiyohiro; Fumika Sugitani; Takenori Fujii; Akari Hosaka; Sachiko Nakamoto; Takashi Amisaki; Eiji Shimizu
Journal:  Yonago Acta Med       Date:  2014-04-28       Impact factor: 1.641

2.  Heart rate recovery and survival in patients undergoing stereotactic body radiotherapy for treatment of early-stage lung cancer.

Authors:  Duc Ha; Kevin Stephans; Humberto Choi; Katrina Zell; Xiao-Feng Wang; Omar A Minai; Daniel P Raymond; Gregory Videtic; Peter J Mazzone
Journal:  J Radiosurg SBRT       Date:  2015

3.  Comparative functional exercise capacity of patients with type 2-diabetes and healthy controls: a case control study.

Authors:  Taofeek Oluwole Awotidebe; Rufus Adesoji Adedoyin; Abraar Olalakan Yusuf; Chidozie Emmanuel Mbada; Rose Opiyo; Frasier Chidyaonga Maseko
Journal:  Pan Afr Med J       Date:  2014-11-07

4.  Usefulness of the 6-minute walk test as a screening test for pulmonary arterial enlargement in COPD.

Authors:  Yutaro Oki; Masahiro Kaneko; Yukari Fujimoto; Hideki Sakai; Shogo Misu; Yuji Mitani; Takumi Yamaguchi; Hisafumi Yasuda; Akira Ishikawa
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2016-11-22

Review 5.  Integrated Telehealth and Telecare for Monitoring Frail Elderly with Chronic Disease.

Authors:  Hulya Gokalp; Joost de Folter; Vivek Verma; Joanna Fursse; Russell Jones; Malcolm Clarke
Journal:  Telemed J E Health       Date:  2018-08-21       Impact factor: 3.536

6.  Is asymptomatic peripheral arterial disease associated with walking endurance in patients with COPD?

Authors:  Kuo-Shao Sun; Ming-Shian Lin; Yi-Jen Chen; Yih-Yuan Chen; Solomon Chih-Cheng Chen; Wei Chen
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-07-29

Review 7.  Activity restriction in mild COPD: a challenging clinical problem.

Authors:  Denis E O'Donnell; Kevin B Gebke
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2014-06-04

8.  A Modified Method for Examining the Walking Pattern and Pace of COPD Patients in a 6-min Walk Test Before and After the Inhalation of Procaterol.

Authors:  Naoto Burioka; Sachiko Nakamoto; Takashi Amisaki; Takuya Horie; Eiji Shimizu
Journal:  Intern Med       Date:  2017-08-01       Impact factor: 1.271

9.  Relationship of CT-quantified emphysema, small airways disease and bronchial wall dimensions with physiological, inflammatory and infective measures in COPD.

Authors:  Kristoffer Ostridge; Nicholas P Williams; Viktoriya Kim; Stephen Harden; Simon Bourne; Stuart C Clarke; Emmanuel Aris; Sonia Mesia-Vela; Jeanne-Marie Devaster; Andrew Tuck; Anthony Williams; Stephen Wootton; Karl J Staples; Tom M A Wilkinson
Journal:  Respir Res       Date:  2018-02-20

10.  Association between six-minute walk test parameters and the health-related quality of life in patients with pulmonary Mycobacterium avium complex disease.

Authors:  Kazuma Yagi; Takanori Asakura; Ho Namkoong; Shoji Suzuki; Takahiro Asami; Satoshi Okamori; Tatsuya Kusumoto; Yohei Funatsu; Hirofumi Kamata; Tomoyasu Nishimura; Makoto Ishii; Tomoko Betsuyaku; Naoki Hasegawa
Journal:  BMC Pulm Med       Date:  2018-07-13       Impact factor: 3.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.